Mice pre-treated with Concanavalin-A largely survived an intra-peritoneal inoculum of 2 X lo7 Serratia marcescens, whereas all control mice died within 15 h of inoculation. A subpopulation of peritoneal macrophages from Con-A pre-treated mice was able to phagocytose the bacteria in vitro (6.7 SEM 1.2% phagocytosing cells) and in vivo (16.9 SEM 2.1%), whereas control phagocytes did not phagocytose S. marcescens. The survival of Con-A pre-treated mice allowed their immunisation with living bacteria, and the antiserum thus produced increased the phagocytosis of S. marcescens in vitro. Control mice largely survived an inoculum of S. marcescens suspended in 50% immune serum, although the bacteria were resistant to the bactericidal activity of that serum. These results suggest that, in contrast to the delayed humoral protection afforded by immunisation, phagocytosis by phagocytes activated by Con-A conferred early protection to mice against experimental infection by S. marcescens.
Introduction
Resistance to the bactericidal activity of normal serum and to phagocytosis probably constitute important virulence factors of the gram-negative bacterium Serratia marcescens. The complement-mediated bactericidal activity of normal serum depends on the covalent fixation of C3b to the target cell surface. A strain of S. marcexens resistant to serum bound less C3b than did a sensitive strain [l] ; this difference in serum sensitivity was attributed to the presence of long 0 antigen (LPS) chains on the surface of the resistant strain, that prevented complement binding. A similar correlation between the presence of 0 antigen and resistance to serum has been reported for several gramnegative bacteria [2-41. On the other hand, the resistance to phagocytosis has often been correlated with the presence of K (capsular) antigens [5-71, whose role in S. marcescens resistance to phagocytosis is unclear. Nevertheless, an analysis of the immunogenic properties of S. marcescens outer membrane has demonstrated that most antigenic sites of the bacterial Mice challenged with a sublethal intraperitoneal inoculum of Escherichiu coli later showed resistance to a lethal dose of the bacteria [9]; the observed increase in bacterial destruction during the early phase of infection was ascribed to non-specific activation of phagocytes. Similar results were observed following intravenous vaccination of mice with formalin-killed S. nzurcescens [lo] , also leading to the conclusion that enhancement of host defence in the early phase of infection depended on non-specific activation of phagocytic functions, However, those studies employing vaccination are inadequate in providing a clear distinction between early humoral immunity and nonspecific activation of phagocytosis. A later study [ 1 11 showed that effective protection of mice vaccinated with formalin-killed S. marcescens was achieved only by the additive effect of humoral immunity and T-cell mediated immunity.
Previous studies demonstrated that the pre-treatment of mice with either concanavalin-A (Con-A) or jacalin increased the rate of clearance of Candida albicans from the peritoneal cavity, increased the phagocytosis of the yeast by peritoneal macrophages, and decreased its dissemination to the viscera [ 121; these effects were ascribed to non-specific activation of cell-mediated immunity (CMI) by Con-A and by jacalin. Because activation of CMI by Con-A avoids the exposure to bacterial antigens employed in vaccination studies, this investigation tested the hypothesis that Con-A could induce phagocytosis of S. marcescens in the early stage of infection and thus confer protection to mice challenged with these bacteria.
Materials and methods

Bacteria and growth conditions
Serratia marcescens strain 0 6 , 14:H4 was isolated from blood of a patient with nosocomial infection at the University Hospital, Faculdade de Medicina de Ribeiriio Preto, SP, Brazil, and was serotyped by Instituto Adolfo Lutz, SZo Paulo, Brazil. The bacteria were grown overnight in Tryptic Soy Broth (TSB; Difco) at 37°C. When the culture reached the required optical density (OD), the bacteria were harvested and transferred to the medium employed in the phagocytic assays. Three dilutions of each culture were plated on agar to determine the number of cfu, to confirm that it corresponded to the bacterial concentration expected from the OD measurement. phagocytic cells were incubated with either lo6 cfu of C. albicans or 0.5% sheep erythrocytes that had been opsonised with rabbit anti-sheep IgG [15, 161. Results were reported as mean PI and SEM; Student's t test was employed for statistical analysis.
Assay of in-vivo phagocytosis and determination of the survival rate
Swiss mice, weighing 25-30 g and 6-8-weeks old, were used in these experiments. One group of mice received 500 ,ug of Con-A in 0.5 ml of PBS and the other 0.5 ml of PBS, administered in a single intraperitoneal dose 96 h before inoculation with 2 X lo7 cfu of an exponential culture of S. marcescens; 1 h after the intraperitoneal inoculation of S. marcescens, the mice were killed and the peritoneal exudate cells were collected and processed for analysis of phagocytosis in vivo. The spleen, liver and kidneys were removed and plated on TSB-agar to evaluate the dissemination of the bacteria.
A group of 17 mice pretreated with Con-A received an inoculum as above and was used for the determination of the survival rate; the control group of eight mice received an intraperitoneal inoculum of S. marcescens 96 h after an intraperitoneal injection of PBS 0.5 ml.
Peritoneal phagocytic cells Immunisation procedure
Peritoneal phagocytes were collected from Swiss mice (weighing 25-30 g)'that had received 500 p g of Con-A (Sigma) in 0.5 ml of phosphate buffered saline (PBS), or this vehicle only, via the intraperitoneal route 4 days earlier. The animals were killed with ether and the phagocytes were collected by washing the peritoneal cavity with 3 ml of RPMI medium (Roswell Park Memorial Institute medium for cell culture; Sigma) with albumin 1%. The phagocytes were allowed to adhere to coverslips for 1 h at 37"C, and the monolayers were then washed in RPMI medium and used in the phagocytic assays.
Ph agocy tosis assay
Monolayers of phagocytic cells were incubated with 2 X 107 cfu of S. marcescens for 1 h at 37°C in 1 ml of RPMI medium buffered to pH 7.0 with 12 mM Hepes. The phagocyte preparations were then washed with RPMI medium, incubated for 15 min with gentamicin 100 mg/L to remove non-ingested bacteria [ 13, 141, washed with PBS, fixed in absolute methanol for 15 min, and stained with haematoxylin eosin. For each preparation 200 cells were counted to evaluate both the percentage of cell types in the peritoneal exudate and the phagocytic index (PI); this index was calculated as the percentage of phagocytosing cells multiplied by the average number of internalised particles. As a control of the phagocytic activity of each sample of macrophages, in each experiment duplicate monolayers of
The 13 mice pretreated with Con-A that survived the inoculation of S. marcescens were further immunised by two intraperitoneal injections of 2 X lo7 cfu of viable S. marcescens, with an interval of 15 days between each inoculation. The mice were bled 7 days after the last boost and their sera were pooled; the antibody titre of the sera was determined by bacterial agglutination. 0-antigen and H-antigen preparations of the S. marcescens strain [17] reacted with the antisera at a dilution of 1600. The sera of control mice did not cause agglutination of S. marcescens at 1 in 1 dilution.
Serum resistance assay
Blood collected from normal mice was allowed to clot at 4°C for 2 h, centrifuged at 4"C, and the separated serum was used immediately. The bacterial resistance to the lethal activity of complement was determined by a rapid turbidimetric assay in microtitration plates [ 181, with modification. Overnight bacterial cultures grown in TSB were diluted 1 in 100 in freshly prepared TSB medium, incubated at 37°C for 90 min with shaking, centrifuged (2500 g, 15 min), resuspended in cold PBS, pH 7.4 (lo7 cfdml), and kept in an ice bath for prompt use. The bacterial suspension was then pipetted into the wells of a microtitration plate, and either normal or immune mouse serum was added to a final concentration of 50%. The plates were shaken briefly and incubated at 37°C; absorbances of triplicates of the samples were read at 0, 60, 120 and 180 min in a spectrophotometer (Titertek Multiskan, model 340) at 620 nm. The serum-sensitive strain E. coli K12-711 was used as control.
Effect of pre-treatment with Con-A on phagocytosis of S. marcescens S. rnarcescens bacteria were not phagocytosed by resident peritoneal macrophages either in the absence or in the presence of mouse serum 10% (Table 1) . Phagocytosis of C. albicans and of opsonised sheep erythrocytes was used as a control of the phagocytic activity of each sample of phagocytes, and it was observed that serum significantly increased the phagocytosis of these cells. On the other hand, macrophages from mice pre-treated with Con-A were able to phagocytose S. rnarcescens both in vitro and in vivo (Table 1) . A subpopulation of macrophages capable of ingesting S. marcescens was increased in number by the pre-treatment of mice with Con-A ( Table 2 ).
Effect of Con-A on mouse survival and inzmunisation
The 5'. marcescens strain was virulent for untreated mice; all eight died within 15 h of bacterial inoculation. However, 13 of the 17 mice pre-treated with Con-A survived the inoculation of s. marcescens and were subsequently immunised with two additional inocula of 2 X 10' viable bacteria. The survival rate of untreated mice was increased from 0 to 75% (6/8) by preincubating the bacterial inoculum for 2 h at 37°C with immune serum diluted 1 in 2.
The peritoneal fluid was intensely haemorrhagic in a second group of eight control mice killed 1 h after bacterial inoculation, and there was a reduction of c. 25 times in the number of cells collected from their peritoneal cavity compared with the mean of 2.6 X lo6 cells/ml observed in the non-inoculated control mice and in previous studies [12] . Although the strain of S. marcescens used in this study was consistently non-haemolytic both on solid and in liquid assay media, the peritoneal fluid collected from 
Conditions in vitro in vivo
Control Con-A 0 0 16.9 (2.1) 6.7 (1.2)
The phagocytic assays in vitro were carried out with phagocytes collccted from mouse peritoneal cavity and incubated for 1 h with the bacteria. For the assays in vivo, the phagocytes were collected 1 h after inoculation of S. marcescens into the peritoneal cavity. Con-A: mice were treated with 500 p g of Con-A 4 days before the assays. The values are mean (SEM) of at least four assays. these group of mice presented a large number of ruptured macrophages, cell nuclei and lysed erythrocytes. On the other hand, the mean number of phagocytes harvested from Con-A pre-treated mice was increased to a mean of 1.2 X lo7 celldm1 1 h after inoculation of the bacteria, as observed in the studies of phagocytosis in vivo.
Titres of the immune antiserum
The pooled serum from the immunised mice agglutinated 5'. marcexens to a titre of 800. The antiserum yielded a titre of 1600 against an 0-antigen and Hantigen preparation of the S. marcexens strain. Neat serum from control mice did not agglutinate the S. marcescens.
Effect of immune serum on the phagocytosis of S. marcescens
Resident peritoneal macrophages phagocytosed S. marcexens in a medium containing the immune serum diluted in 1 in 1000, whereas in a medium containing control mouse serum they failed to phagocytose the bacteria (Fig. 1) . Addition of control mouse serum to the medium containing the antiserum caused no further increase in phagocytosis (p > 0.05, Fig. 1 ).
Sensitivity of S. marcescens to the bactericidal effect of serum S. rnarcescens was resistant to the lytic action of 50% normal or immune mouse serum, as shown in Fig. 2 Escherichia coli K12, which is sensitive to lysis by complement, was used as a control.
Discussion
Peritoneal macrophages from mice pre-treated with Con-A were able to phagocytose 5'. marcescens both in vivo and in vitro, whereas resident phagocytes from control mice were not. However, these resident macrophages were capable of phagocytosing either opsonised sheep erythrocytes or C. albicans, which shows that they were capable both of opsonophagocytosis and lectinophagocytosis. Moreover, addition of fresh mouse serum to the phagocytic assay did not cause complement-mediated phagocytosis of the bacteria by resident phagocytes, in agreement with a previous observation [l] that a strain of S. nzarcescens resistant to serum (as was the one used in this study) bound less C3b than a sensitive strain. Addition of cellfree exudate collected from the peritoneal cavity of mice pre-treated with Con-A to the in-vitro phagocytic assay was also ineffective in c\ausing phagocytosis by control phagocytes (data not shown). As the macrophages used in the in-vivo assay were collected shortly (1 h) after inoculation of the bacteria, these results show that the early phagocytosis of 5'. marcescens can be attributed to an activation of phagocytes by Con-A and not to humoral immunity. Furthermore, macrophages collected from mice pre-treated with Con-A, but not inoculated with S. marcescens, phagocytosed the bacteria in vitro, corroborating the conclusion that a subpopulation of macrophages activated by Con-A was responsible for the phagocytosis of S. marcescens.
Mice pre-treated with Con-A survived an otherwise lethal inoculum of S. marcescens, whereas control mice died within 15 h of inoculation. This short survival period of the control mice suggests that the protection afforded by Con-A can be attributed to the early activation of phagocytosis discussed above. Con-A induces secretion of interferon gamma (IFN-y) and other cytokines, and consequently causes activation of the bactericidal potential of macrophages [ 19,201. Therefore, it seems likely that a particular subset of phagocytes (Table 2) was activated by Con-A-induced release of IFN-y, and that this subset of phagocytes was responsible for the protection of mice against a lethal dose of S. marcescens.
The antiserum obtained from Con-A pre-treated mice that survived bacterial inoculation was effective in the opsonisation of S. marcescens, as shown by its induction of phagocytosis in vitro by resident macrophages. As immune complexes of IgG and IgM can bind to rabbit polymorphonuclear leucocytes [2 11, but only the IgG complexes are readily phagocytosed, these results suggest that IgG present in the immune serum mediated the phagocytosis of 5'. marcescens by non-activated phagocytes. Furthermore, pre-incubation of S. marcescens with the antiserum protected control mice against a lethal dose of the bacteria; because the bacteria were resistant to the lytic activity of 50% serum, either normal or immune, this protection afforded by the antiserum was possibly caused by induction of phagocytosis in vivo. Bacteria resistant to the lytic activity of normal serum and resistant to phagocytosis are often capsulated [ 5-71, and negative staining with India ink revealed that the strain used in this study was capsulate, corroborating the above results (picture not shown).
These findings demonstrate that the pre-treatment with Con-A protected mice against experimental infection by S. nzarcescens, and support the hypothesis that activation of phagocytes constituted the major, if not the only, early mechanism of defence against S. marcescens.
